Fiji vs Jordan: Cause of death, by non-communicable diseases, ages 5-14, female
Fiji
41.1%
in 2021
Jordan
41.8%
in 2021
Fiji rank
88th
Jordan rank
86th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Fiji
- Jordan
How they compare
Jordan currently reports 41.8% against 41.1% in Fiji, a difference of 0.7%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Jordan ahead.
Fiji ranks 88th and Jordan ranks 86th of 184 countries.
Across the 3 decades both report, Fiji averaged higher in 1 and Jordan in 2.
Head to head by decade
| Decade | Fiji | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.2% | 49.3% | 7.1% | Jordan |
| 2010s | 46.4% | 46.9% | 0.4% | Jordan |
| 2020s | 44.8% | 44.7% | 0.0% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Fiji or Jordan?
- Jordan, at 41.8% against 41.1% in Fiji as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Fiji and Jordan?
- 0.7%, with Jordan ahead.
- How many years of comparable data are there for Fiji and Jordan?
- 6 years are reported by both, from 2000 to 2021.
- How do Fiji and Jordan rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Fiji ranks 88th and Jordan ranks 86th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.